Found: 25
Select item for more details and to access through your institution.
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1533, doi. 10.1007/s10637-019-00889-y
- By:
- Publication type:
- Article
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 634, doi. 10.1007/s10637-017-0473-9
- By:
- Publication type:
- Article
Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038231
- By:
- Publication type:
- Article
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 4, p. 175
- By:
- Publication type:
- Article
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
A phase 2 study of oral MKC-1, an inhibitor of importin-[beta], tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1614, doi. 10.1007/s10637-011-9708-3
- By:
- Publication type:
- Article
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00561-6
- By:
- Publication type:
- Article
Phase 2 Study of Cetuximab in Patients With Advanced Hepatocellular Carcinoma.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 581, doi. 10.1002/cncr.22829
- By:
- Publication type:
- Article
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 10, p. 2482, doi. 10.1002/cncr.22264
- By:
- Publication type:
- Article
A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 5, p. 934
- By:
- Publication type:
- Article
Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 5, p. 661, doi. 10.1007/s00280-006-0411-6
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 3, p. 285, doi. 10.1007/s00280-006-0265-y
- By:
- Publication type:
- Article
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1247, doi. 10.1007/s40273-022-01196-w
- By:
- Publication type:
- Article
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 558, doi. 10.1007/s10120-024-01466-w
- By:
- Publication type:
- Article
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 10, p. e1324, doi. 10.1093/oncolo/oyae087
- By:
- Publication type:
- Article
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 425, doi. 10.1093/oncolo/oyad002
- By:
- Publication type:
- Article
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2014, v. 19, n. 6, p. 637, doi. 10.1634/theoncologist.2014-0086
- By:
- Publication type:
- Article
Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 377, doi. 10.1634/theoncologist.2012-0378
- By:
- Publication type:
- Article
Preoperative Cetuximab, Irinotecan, Cisplatin, and Radiation Therapy for Patients With Locally Advanced Esophageal Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 3, p. 281, doi. 10.1634/theoncologist.2012-0208
- By:
- Publication type:
- Article
Feasibility of Computer-Based Self-Administered Cancer-Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 64, doi. 10.1634/theoncologist.2012-0241
- By:
- Publication type:
- Article
Eisenbahnüberführung über die Salzach bei Schwarzach/St. Veit.
- Published in:
- Stahlbau, 2017, v. 86, n. 9, p. 772, doi. 10.1002/stab.201710531
- By:
- Publication type:
- Article